Dec
9
2021
On demand

Putting the patient first: New modalities of manufacturing for cell therapy through real-time process changes

How can you build a process that accounts for the countless possibilities of product composition? Or for the health of the patient from whom the therapy will be manufactured? Or for how those patient cells will transform and react to the manufacturing process? In this webinar we will explore new modalities for cell therapy manufacturing that change the current paradigm of a fixed manufacturing process, enabling for a more personalized approach to achieve improved clinical outcomes.

  • Currently in the cell therapy field, a fixed manufacturing process is used despite the input product being variable
  • With the right technologies and process knowledge, it is possible to enable a flexible and adaptable manufacturing process
  • Patients with varying levels of health can benefit from a flexible process to achieve better clinical outcome
  • The future of cell therapy manufacturing needs to evolve to a more flexible manufacturing modality


Chelsea C. White III

Schneider National Chair of Transportation & Logistics, H. Milton Stewart School of Industrial & Systems Engineering, Georgia Institute of Technology

Chelsea C. White holds the Schneider National Chair of Transportation and Logistics at the Georgia Institute of Technology. His research interests include stochastic optimization with application to the design and operation of resilient and competitive manufacturing supply chains. An application area of most recent interest is autologous and allogeneic cell therapy manufacturing, based on real-time therapy and patient data and how it forms the basis for patient priority ranking and capacity planning & reagent replenishment policy determination.

Professor Ben Wang

Gwaltney Chair in Manufacturing Systems, Georgia Tech College of Engineering Professor in Materials Science & Engineering, Executive Director, Georgia Institute of Technology

Ben Wang is the Eugene C. Gwaltney Jr. Chair in Manufacturing Systems and Professor in the Stewart School of Industrial & Systems Engineering, and Professor in the School of Materials Science and Engineering at Georgia Tech. In addition, Wang serves as the Executive Director of the Georgia Tech Manufacturing Institute. Wang is a Fellow of the Institute of Industrial Engineers, the Society of Manufacturing Engineers and the Society for the Advancement of Material and Process Engineering. Wang's professional focus is on strengthening manufacturing competitiveness through technology, infrastructure, workforce, and policy.

He served as Vice Chair (2016–2017) and Chair (2017–2019) of the National Materials and Manufacturing Board, National Academies of Sciences, Engineering and Medicine (NASEM). Under his leadership, the Board oversaw several landmark studies including A Vision for Center-Based Engineering Research (a blueprint for the current NSF Generation 4 Engineering Research Centers), Frontiers of Materials Research: A Decadal Survey, and Strategic Long-Term Participation by DOD in Its Manufacturing USA Institutes.

His research lies at the nexus of advanced manufacturing, innovative materials, and data analytics and is widely acknowledged as a pioneer in nanomaterials science and engineering. Creativity and innovation are central to Wang’s R&D endeavors. He has a portfolio of issued and applied-for patents that now exceeds 35, and 15 of which have been licensed or in discussion for commercialization. Wang is a technical advisor to WEAV3D, an additive manufacturing startup.

Dr. Kan Wang

Senior Research Engineer, Georgia Tech Manufacturing Institute, Georgia Institute of Technology

Dr. Kan Wang received the B.S. degree in theoretical and applied mechanics from Peking University, Beijing, China, in 2005, the M.S. degree in aircraft design from Beihang University, Beijing, in 2007, and the Ph.D. degree in industrial and manufacturing engineering from Florida State University, Tallahassee, FL, USA, in 2013. He is currently a Senior Research Engineer with the Georgia Tech Manufacturing Institute, Georgia Institute of Technology, Atlanta, GA,USA. His current research interests include cell manufacturing, tissue engineering, biomanufacturing supply chain, additive manufacturing, and printed electronics technologies.

SPEAKERS

Chelsea C. White III
Schneider National Chair of Transportation & Logistics, H. Milton Stewart School of Industrial & Systems Engineering, Georgia Institute of Technology
Professor Ben Wang
Gwaltney Chair in Manufacturing Systems, Executive Director, Georgia Institute of Technology
Dr. Kan Wang
Senior Research Engineer, Georgia Tech Manufacturing Institute, Georgia Institute of Technology

You might also like

Thinking translational: Things to consider in CAR T cell research workflows

S Rösch, PhD
Saskia Rösch, PhD
Saskia Rösch, PhD
Global Product Manager at Miltenyi Biotec
22 Jun 2022
34
Days
23
Hrs
12
Min
Register

Optimizing mRNA purification conditions by using a Design of Experiments...

J England
Jenny England
Jenny England
Application Scientist and Innovation Leader at Thermo Fisher Scientific
14 Jun 2022
26
Days
23
Hrs
12
Min
Register

Monitoring of circulating CAR T cells

A Graband,
D Hünecke,
D Bremm
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
Dr. Sabine Hünecke
Dr. Sabine Hünecke
Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
Dr. Melanie Bremm
Dr. Melanie Bremm
Deputy Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
31 May 2022
12
Days
23
Hrs
12
Min
Register

Improving T cell therapy manufacturing processes with automation and...

E Zynda, PhD
Evan Zynda, PhD
Evan Zynda, PhD
Staff Scientist, Cell Biology at Thermo Fisher Scientific
26 May 2022
7
Days
23
Hrs
12
Min
Register

Streamlined workflow solutions for cell and gene therapy analytics

A Graband
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
24 May 2022
5
Days
23
Hrs
12
Min
Register